Critical Insights From Pharming Analyst Ratings: What You Need To Know
Critical Insights From Pharming Analyst Ratings: What You Need To Know
來自Pharming分析師評級的重要見解：您需要知道的事項
In examining recent analyst actions...6 analysts have expressed a variety of opinions on Pharming (NASDAQ:PHAR) over the past quarter, offering a diverse set of opinions from bullish to bearish.
在過去的一個季度裏，6位分析師對pharming group（納斯達克：PHAR）表達了多種看法，從看好到看淡。
The following table provides a quick overview of their recent ratings, highlighting the changing sentiments over the past 30 days and comparing them to the preceding months.
下表提供了他們最近的評級概況，突出了過去30天內情緒的變化，並將其與之前的月份進行了比較。
Analysts have recently evaluated Pharming and provided 12-month price targets. The average target is $32.0, accompanied by a high estimate of $37.00 and a low estimate of $14.00. This current average has decreased by 10.61% from the previous average price target of $35.80.
分析師最近對Pharming進行了評估，並提供了12個月的價格目標。平均目標爲32.0美元，最高估計爲37.00美元，最低估計爲14.00美元。當前的平均目標較之前的35.80美元平均價格目標下降了10.61%。
Understanding Analyst Ratings: A Comprehensive Breakdown
分析師評級：全面解析
In examining recent analyst actions...
在審查最近...
登入免費觀看全文
登入/註冊
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。